Major Sponsor:




Contributing Sponsor:




Login Form






Lost Password?
No account yet? Register
Grand Rounds in Urology, Volume 8, Issue 4

 

GRU Volume 8, Issue 2

Statement of Need

Urology experts generally agree that the urological patient will benefit greatly if the treatment provided is the result of a combined effort among the specialists involved in patient care. The collaboration of experts from various fields is thus necessary to improve urological research and enhance medical practice worldwide and to close the practice gap found among current treatment protocols. The 2009 Future Directions in Urology Symposium (FDUS) brought together leading urologists, radiologists, radiation oncologists, and medical oncologists to provide a forum for sharing knowledge and experience with the objective of facilitating multidisciplinary approaches that aim to optimize disease prevention and diagnostic therapeutic interventions. A four-day symposium was held, featuring state-ofthe- art lectures, case reports, a review of clinical trials, and treatment guideline analysis. Group discussion assisted in improving competence and knowledge and addressed four Institute of Medicine (IOM) Universal Physician competencies: to provide patient-centered care, to work in interdisciplinary teams, to employ evidence-based practice, and to apply quality improvement.

Read more...
 
Grand Rounds in Urology, Volume 8, Issue 3

 

GRU Volume 8, Issue 2

Statement of Need

Genitourinary (GU) cancer refers to abnormal cell growth leading to the formation of tumors in the genital and/or urinary organs. Most genitourinary cancers occur in the prostate (in men), kidneys, or bladder. The American Cancer Society’s 2009 report estimates that 37%, or approximately 283,468 of the estimated 766,130 cases of cancer in men diagnosed in the US will involve a type of genitourinary cancer. Among cancer deaths in men, genitourinary cancers will account for nearly 20% (55,582) of the expected 292,540 deaths. This activity will review both the need for improved tumor markers to diagnose and prevent GU cancers, and ongoing research in treatment models for the various types GU cancers.

Read more...
 
Advertisement